- Anti Nuclear Antibody (ANA) By IFA (HEP-2) (1)
- ANA IFA
- Anti Phospholipid IgG Antibodies (1)
- Phospholipid IgG
- Anti Phospholipid IgM Antibodies (1)
- Phospholipid IgM
- Ds-DNA (1)
- Ds-DNA Antibody
- SM Antibody (1)
- SM Antibody
Systemic Lupus Erythematosus (SLE) Panel – Comprehensive Evaluation for Lupus and Related Autoimmune Conditions
If you are experiencing a range of unexplained symptoms and suspect an autoimmune condition like Systemic Lupus Erythematosus (SLE), the SLE Panel is a specialized diagnostic test designed to provide valuable insights for accurate diagnosis and personalized management.
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease that can affect multiple organs and systems in the body. The SLE Panel includes a set of tests that target specific autoantibodies commonly associated with SLE and related conditions.
The SLE Panel comprises the following tests:
Anti Nuclear Antibody (ANA) By IFA (HEP-2): This test is the primary screening tool for autoimmune diseases like SLE. It detects antibodies targeting various components within the cell nucleus.
Anti Phospholipid IgG Antibodies: This test assesses the presence of IgG antibodies against phospholipids, which are essential components of cell membranes. Elevated levels may indicate an increased risk of blood clots and certain pregnancy complications.
Anti Phospholipid IgM Antibodies: Similar to the IgG test, this test measures IgM antibodies against phospholipids, which can also contribute to blood clotting disorders.
Ds-DNA: This test detects antibodies against double-stranded DNA, which are highly specific to SLE. Elevated levels of Ds-DNA antibodies are strongly associated with active SLE.
SM Antibody: This test detects antibodies against Smith (Sm) antigen, another specific marker for SLE.
With the results of the SLE Panel, your healthcare provider can:
Confirm the Diagnosis: The presence of specific autoantibodies in the panel can help confirm the diagnosis of SLE or related autoimmune conditions.
Guide Treatment Decisions: Understanding the autoantibody profile allows for tailored treatment plans to manage symptoms and prevent disease flares.
Monitor Disease Activity: Monitoring changes in autoantibody levels over time can help gauge disease activity and guide treatment adjustments.
Take the first step towards managing your health with the SLE Panel – a crucial tool in diagnosing and managing Systemic Lupus Erythematosus.